Comparative 12-month cardiometabolic impact of semaglutide vs tirzepatide: a synthetic propensity-matched analysis

25 April 2026 (08:30 - 12:30)
Organised by: Logo
Congress Presentation Part of: Poster session (3) Cardiovascular Risk Assessment EAPC Premium Access ESC Preventive Cardiology 2026 European Association of Preventive Cardiology (EAPC)

ESC 365 is supported by

ESC 365 is supported by